Moluskum Kontagiosum

01Pathophysiology

Molluscum contagiosum is caused by the Molluscum Contagiosum Virus (MCV), a member of the Poxviridae family. MCV is the largest double-stranded DNA virus known to infect humans. There are four subtypes (MCV-1 through MCV-4), with MCV-1 being the most common overall and in children, and MCV-2 being more frequently associated with sexually transmitted infections in adults.

The virus infects keratinocytes in the epidermis and replicates exclusively within the cytoplasm of host cells, never integrating into the host genome. As the virus replicates, it produces large intracytoplasmic inclusion bodies that push the cell nucleus to the periphery. These inclusions are the Henderson-Patterson bodies (also called molluscum bodies), which are pathognomonic on histology. The progressive accumulation of viral particles causes the keratinocytes to enlarge dramatically and eventually rupture, releasing the waxy, caseous core that is clinically visible.

A key concept is that MCV encodes immune evasion proteins that suppress local innate and adaptive immune responses. The virus produces chemokine homologs and inhibitors of apoptosis, NF-kB signaling, and MHC class I antigen presentation. This is why lesions persist for months despite being superficial, and why the host does not mount an immediate inflammatory response. The central umbilication seen clinically corresponds to the area where virus-laden keratinocytes degenerate and form a crater-like depression filled with viral debris. This feature directly reflects the underlying epidermal pathology and is the single most recognizable clinical clue.

In immunocompromised patients, particularly those with HIV/AIDS and a CD4 count below 200 cells/mcL, the virus replicates unchecked due to impaired T-cell-mediated immunity. This results in hundreds of lesions, larger papules (sometimes exceeding 1 cm, termed "giant molluscum"), and resistance to standard treatments. The resolution of lesions in these patients often correlates with immune reconstitution following initiation of ART.

02Classification and Clinical Manifestation

03Diagnostic Workup

Diagnostic reasoning. In the vast majority of cases, molluscum contagiosum is a clinical diagnosis. The combination of multiple dome-shaped papules with a visible central umbilication in a child or young adult is sufficient to make the diagnosis without any laboratory testing. Dermoscopy can be helpful in confirming ambiguous cases, as the polylobular central structure is highly characteristic.

Biopsy is reserved for atypical presentations where the clinical picture overlaps with other conditions. This is particularly relevant in immunocompromised patients, where disseminated cryptococcosis and histoplasmosis can produce umbilicated papules that closely mimic molluscum. If an HIV-positive patient presents with widespread umbilicated papules and systemic symptoms (fever, weight loss, meningeal signs), biopsy with appropriate stains (GMS, mucicarmine for Cryptococcus; GMS, Wright for Histoplasma) is essential to exclude these life-threatening infections.

An important clinical pearl: if an adult presents with genital molluscum, screen for other sexually transmitted infections (chlamydia, gonorrhea, syphilis, HIV), as co-infection is common. If an adult presents with widespread facial molluscum without known immunosuppression, HIV testing is the next step.

04Management and Treatment

Management reasoning. The most important concept for exam purposes is that observation is the first-line approach in immunocompetent children with limited disease. Parents often request treatment, but the condition is benign and self-resolving. Intervention is indicated when lesions are symptomatic, cosmetically distressing, or located in areas prone to autoinoculation (e.g., periocular, genital).

When treatment is pursued, physical destruction (cryotherapy or curettage) offers the most immediate results. Cantharidin is a popular in-office option because it is painless at application and well-tolerated in children, though the delayed blistering reaction must be explained to parents.

For immunocompromised patients, the treatment paradigm shifts entirely. Destructive therapy alone is insufficient because the underlying immune defect allows continuous viral replication. The cornerstone of management is restoring immune function, most commonly through ART in HIV-positive patients. Topical cidofovir is reserved for refractory cases.

Contraindications to note: podophyllotoxin is absolutely contraindicated in pregnancy. Imiquimod should be used with caution on mucosal surfaces due to the risk of severe local inflammation. Cantharidin should not be applied to the face, genitals, or perianal area due to the risk of scarring and severe blister formation.

05Differential Diagnosis and Distractors

06Traps and High-Yield Pearls

The most common way students lose points on molluscum contagiosum questions is by failing to recognize the condition in an immunocompromised patient and instead selecting a disseminated fungal infection, or vice versa. When a vignette describes an HIV-positive patient with a very low CD4 count and widespread umbilicated facial papules, students often default to molluscum because of the classic morphology. However, if the vignette includes systemic symptoms (fever, weight loss, headache, meningeal signs, hepatosplenomegaly, or pancytopenia), the answer shifts to disseminated cryptococcosis or histoplasmosis, and the next step is biopsy with appropriate stains, not observation. The discriminator is always whether the patient is systemically ill or has isolated skin findings.

A second common trap involves the "inflamed molluscum" scenario. A child with known molluscum returns because several lesions have become red, swollen, and tender. Students are tempted to choose antibiotics for bacterial superinfection. In most cases, this is the "beginning of the end" (BOTE) reaction, where the host immune system is finally recognizing and attacking the virus. The appropriate answer is reassurance and observation unless there is purulent drainage, warmth, or spreading cellulitis.

The third pearl is about management sequencing. For immunocompetent children, the first-line answer is almost always observation. Students who pick cryotherapy or curettage as first-line are penalized. Physical destruction is reserved for cases where lesions are persistent, symptomatic, or in cosmetically or functionally sensitive areas.

Finally, remember that Henderson-Patterson bodies are pathognomonic and represent the histologic gold standard. If a question describes intracytoplasmic eosinophilic inclusion bodies that push the nucleus to the periphery, the answer is molluscum contagiosum regardless of the clinical context provided.

The core competency being tested is the ability to integrate the clinical morphology (umbilicated papules), the patient context (immunocompetent vs. immunocompromised), and the appropriate management response (observation vs. active treatment vs. systemic workup) into a single coherent clinical decision.